Continuous Glucose Monitoring (CGM)

CGM for Adults with Type 2 Diabetes Not on Insulin Therapy: The CONNECT Randomized Controlled Trial

by Prateek Chopra | June 24, 2026 | Diabetes Conferences | ADA 2026 Study Objective Trial Design Study Assessments Baseline Characteristics Baseline Medication Use Clinical Implications Baseline findings from the CONNECT trial highlight persistent gaps in glycemic management among adults with non-insulin-treated T2D. The ongoing study will determine whether CGM can improve glycemic outcomes and support more effective diabetes management […]

CGM for Adults with Type 2 Diabetes Not on Insulin Therapy: The CONNECT Randomized Controlled Trial Read Post »

Putting It All Together: Strategies for Implementation

by Prateek Chopra | June 22, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Person-Centered Care Framework: Foundations of E ective Implementation: Lifestyle Interventions: Weight Management Strategies: Role of Technology: Health-System Transformation: Equity and Access Considerations: Remaining Knowledge Gaps: Successful implementation of contemporary T2D care requires a personalized, multidisciplinary approach that combines lifestyle modification, evidence-based therapies, digital health technologies, and

Putting It All Together: Strategies for Implementation Read Post »

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Modeling Approach: Intervention: Projected Clinical Outcomes: Benefits in Type 1 Diabetes: Benefits in Type 2 Diabetes: Quality of Life and Economic Outcomes: Clinical Implications: Long-term projections based on the REST intervention demonstrated meaningful reductions in diabetes- and cardiovascular-related complications,

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin Read Post »

Scroll to Top